Arcutis Biotherapeutics, Inc.
Arcutis Biotherapeutics, Inc. scores highest on Nitro (90) and lowest on Price (7). Its PosiPenta is 57.65 out of 100, around the middle of similar companies.
On the Penta Grid this week, Arcutis Biotherapeutics, Inc. is Grid #171 of 837 in the Healthcare sector in United States, and Grid #892 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Arcutis Biotherapeutics, Inc. | 57.65 | 7 | 87 | 90 | 58 | 46 |
| Relay Therapeutics, Inc. | 46.27 | 17 | 30 | 81 | 60 | 44 |
| iRhythm Holdings, Inc. | 41.61 | 3 | 80 | 42 | 38 | 45 |
| Indivior Pharmaceuticals, Inc. | 68.09 | 39 | 79 | 74 | 98 | 51 |
| Adaptive Biotechnologies Corporation | 43.46 | 2 | 62 | 81 | 32 | 41 |
| ICU Medical, Inc. | 62.73 | 33 | 91 | 83 | 52 | 55 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 131.00 |
| P/B ratio | 16.42 |
EEarnings
| Trailing EPS | ₹20.84 |
| Forward EPS | ₹119.97 |
NNitro
| Price | 2729.68 |
| 52-week high | 3009.09 |
| 52-week low | 1827.53 |
| Fall from 52-week high | 9.3% |
TTorque
| Return on equity (ROE) | 15.86% |
| Debt-to-equity | 0.52 |
AAnchor
| Beta (price swings) | 1.58 |
| Market cap | ₹34,309 Cr |
| Insider holding | 1.77% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Arcutis Biotherapeutics, Inc.'s PosiPenta score?
Arcutis Biotherapeutics, Inc.'s PosiPenta is 57.65 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Arcutis Biotherapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Arcutis Biotherapeutics, Inc. is Grid #171 of 837 in the Healthcare sector in United States, and Grid #892 of 4,000 in United States.
Which PosiPenta pillar is strongest for Arcutis Biotherapeutics, Inc.?
Nitro (momentum), with a score of 90 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Arcutis Biotherapeutics, Inc.?
Price (valuation), with a score of 7 out of 100: much weaker than most similar companies.
Has Arcutis Biotherapeutics, Inc.'s PosiPenta changed since last week?
Yes, it rose 3.64 points, from 54.01 to 57.65.
PositoAI is for research and education only and is not investment advice.